19|28|Public
2500|$|The Federal Plant Pest Act {{defines a}} plant pest as [...] "any living stage (including active and dormant forms) of insects, mites, nematodes, slugs, snails, protozoa, or other {{invertebrate}} animals, bacteria, fungi, other parasitic plants or reproductive parts thereof; viruses; or any organisms similar to or allied {{with any of}} the foregoing; or any <b>infectious</b> <b>substances,</b> which can directly or indirectly injure or cause disease or damage in or to any plants or parts thereof, or any processed, manufactured, or other products of plants..." [...] The Animal and Plant Health Inspection Service (APHIS) categorizes giant African snails as a [...] "quarantine significant plant pest." [...] The United States does not allow live giant African snails into the country under any circumstances. It is illegal to own or to possess them. APHIS vigorously enforces this regulation and destroys or returns these snails to their country of origin.|$|E
5000|$|According to Title 18 of the United States Code, [...] "... {{the term}} [...] "toxin" [...] means the toxic {{material}} or product of plants, animals, microorganisms (including, {{but not limited}} to, bacteria, viruses, fungi, rickettsiae or protozoa), or <b>infectious</b> <b>substances,</b> or a recombinant or synthesized molecule, whatever their origin and method of production..." ...|$|E
50|$|Later, they {{determine}} {{the heart attack}} was not caused by the treatment. House then sends them to run tests and look for <b>infectious</b> <b>substances</b> in the cafeteria. House confides to Wilson that he saw Chase, but Wilson says Chase is in Scottsdale, Arizona, and suggests House is feeling repressed guilt. House is not amused.|$|E
5000|$|Category A, UN 2814 - <b>Infectious</b> <b>substance,</b> {{affecting}} humans: An <b>infectious</b> <b>substance</b> {{in a form}} {{capable of}} causing permanent disability or life-threatening or fatal disease in otherwise healthy humans or animals when exposure to it occurs.|$|R
5000|$|Category A, UN 2900 - <b>Infectious</b> <b>substance,</b> {{affecting}} animals (only): An <b>infectious</b> <b>substance</b> {{that is not}} in a form generally {{capable of}} causing permanent disability or life-threatening or fatal disease in otherwise healthy humans and animals when exposure to themselves occurs.|$|R
50|$|Flexal {{virus is}} listed as a UN 2814 Category A <b>infectious</b> <b>substance.</b>|$|R
5000|$|The Federal Plant Pest Act {{defines a}} plant pest as [...] "any living stage (including active and dormant forms) of insects, mites, nematodes, slugs, snails, protozoa, or other {{invertebrate}} animals, bacteria, fungi, other parasitic plants or reproductive parts thereof; viruses; or any organisms similar to or allied {{with any of}} the foregoing; or any <b>infectious</b> <b>substances,</b> which can directly or indirectly injure or cause disease or damage in or to any plants or parts thereof, or any processed, manufactured, or other products of plants..." [...] The Animal and Plant Health Inspection Service (APHIS) categorizes giant African snails as a [...] "quarantine significant plant pest." [...] The United States does not allow live giant African snails into the country under any circumstances. It is illegal to own or to possess them. APHIS vigorously enforces this regulation and destroys or returns these snails to their country of origin.|$|E
40|$|February 2006. "Laboratory contacts. [...] Emergency {{response}} procedures. [...] Bioterrorism response procedures. [...] General requirements. [...] Definition {{of terms}} and abbreviations. [...] Services available at U. S. CDC. [...] Laboratory services. [...] Clinical testing. [...] Environmental testing. [...] Environmental laboratory certification. [...] Laboratory improvement and training services. [...] Appendix A. Specimen collection (venipuncture). [...] Appendix B. Communicable diseases laboratory test requisition. [...] Appendix C. Clinical supplies requisition form. [...] Appendix D. Fee for service schedule. [...] Appendix E. CDC 50. 34 REV. 09 / 2002. [...] Appendix F. Guidelines for {{packaging and shipping}} diagnostic specimens by air transport (Express mail). [...] Appendix G. Guidelines for packaging and shipping diagnostic specimens by air (Federal Express). [...] Appendix H. Guidelines for packaging and shipping diagnostic specimens using the United States Postal Service (USPS) or private courier by ground. [...] Appendix I. Example of shipper's declaration for dangerous goods. [...] Appendix J. Guidelines for shipping <b>infectious</b> <b>substances.</b> [...] Appendix K. Indicative examples of <b>infectious</b> <b>substances</b> included in category A in any form unless otherwise indicated (3. 6. 2. 2. 2. 1 - MAR 05). [...] Appendix L. Indicative examples of <b>infectious</b> <b>substances</b> included in category A in any form unless otherwise indicated (3. 6. 2. 2. 2. 1 - MAR 05). Mode of access: Internet...|$|E
40|$|In <b>infectious</b> <b>substances</b> transportation; to {{minimize}} the exposure of sender, receiver, transporter and the environment to <b>infectious</b> <b>substances</b> due to the incidents such as breakage and leakage during any step of transportation process from sender to receiver, rules and regulations have been established. For safe transportation and suitable packaging, definitions and classifications of transported materials are identified by international standards. All international regulations {{are in line with}} UN expert committee’s dangerous materials transportation recommendations. UPU (Universal Postal Union) also reflects these guidelines to their regulations. ICAO (International Civil Aviation Organization) and IATA (International Air Transportation Association) incorporated UN’s guidelines to their own regulations. WHO supplies consultancy support to all these organizations. IATA issues updated shipping guidelines for infectious materials transportation every year. The aim of this compilation is to inform how infectious materials should be transported based on international transportation regulations. In this review it was aimed to give information about how infectious materials should be transported based on international air transportation regulations...|$|E
5000|$|The act {{broadly defined}} several terms related to {{biological}} warfare (BW). Those terms were: vector, toxin, biological agent and delivery system. BWATA defined a biological agent as: any micro-organism, virus, <b>infectious</b> <b>substance,</b> or biological product {{that may be}} engineered {{as a result of}} biotechnology, or any naturally occurring or bioengineered component of any such microorganism, virus, <b>infectious</b> <b>substance,</b> or biological product, capable of causing death, disease, or other biological malfunction in a human, an animal, a plant, or another living organism; deterioration of food, water, equipment, supplies, or material of any kind or deleterious alteration of the environment ...|$|R
5000|$|In {{recent years}} certain critics have claimed the U.S. stance on {{biological}} warfare {{and the use}} of biological agents has differed from historical interpretations of the BWC. For example, it is said that the U.S. now maintains that the Article I of the BWC (which explicitly bans bio-weapons), does not apply to [...] "non-lethal" [...] biological agents. Previous interpretation was stated to be in line with a definition laid out in Public Law 101-298, the Biological Weapons Anti-Terrorism Act of 1989. That law defined a biological agent as: any micro-organism, virus, <b>infectious</b> <b>substance,</b> or biological product that may be engineered as a result of biotechnology, or any naturally occurring or bioengineered component of any such microorganism, virus, <b>infectious</b> <b>substance,</b> or biological product, capable of causing death, disease, or other biological malfunction in a human, an animal, a plant, or another living organism; deterioration of food, water, equipment, supplies, or material of any kind... According to the Federation of American Scientists, U.S. work on non-lethal agents exceeds limitations in the BWC.|$|R
500|$|During the 1960s, two London-based researchers, {{radiation}} biologist Tikvah Alper and biophysicist John Stanley Griffith, {{developed the}} hypothesis that some transmissible spongiform encephalopathies are caused by an infectious agent consisting solely of proteins. Earlier investigations by E. J. Field into scrapie and kuru had identified the transfer of pathologically inert polysaccharides that only become infectious in the host. Alper and Griffith wanted {{to account for the}} discovery that the mysterious infectious agent causing the diseases scrapie and Creutzfeldt–Jakob disease resisted ionizing radiation. [...] (A single ionizing [...] "hit" [...] normally destroys an entire infectious particle, and the dose needed to hit half the particles depends {{on the size of the}} particles. Empirical results of ionizing doses applied to the unknown <b>infectious</b> <b>substance</b> evidenced an <b>infectious</b> particle size too small to be a viral mechanism.) ...|$|R
40|$|For {{information}} on the transportation of etiologic agents (<b>infectious</b> <b>substances)</b> and related materials, such as specimens for testing, please refer to regulations issued in the Department of Transportation (DOT) final rule “Hazardous Materials: Infectious Substances; Harmonization with the United Nations Recommendations ” (49 CFR Parts 171 – 178; June 2, 2006). The rule revises the definition of an infectious substance from Risk Groups 1 – 4 to a two-category system adopted by the World Health Organization, wherein Category A is for high-risk substances and Category B is for all other substances. The result {{is a set of}} standards that are easier to use and impose a high level of safety appropriate to the degree of risk and conditions of transport. The rule also revises packaging, exceptions, and other shipping requirements for <b>infectious</b> <b>substances</b> to make them more consistent with requirements in international standards. For more information, please contact the DOT Hazardous Materials Information Center at 1 - 800 - 467 - 4922 from 9 : 00 a. m. – 5 : 00 p. m. Eastern time, Monday–Friday, except federal holidays. For {{information on}} specific regulations, refer to...|$|E
40|$|Among {{hazardous}} materials {{those which are}} most dangerous fall into three categories: chemical, biological, and radioactive. The DOT hazard classes for these three categories are Hazard Class 2. 3 (poisonous gases) and 6. 1 (toxic substances) for chemical hazards, Hazard Class 6. 2 (<b>infectious</b> <b>substances)</b> for biological hazards and Hazard Class 7 for radioactive material (RAM) hazards. The packaging requirements for chemical and biological hazards are outlined and compared with RAM packaging requirements. RAM packages {{are found to be}} able to withstand much more severe performance tests than packages for other, more lethal hazards...|$|E
40|$|The most {{important}} {{function of the}} skin is to form a barrier between {{the body and the}} external environment. The epidermal barrier prevents transepidermal water loss from the skin, but also serves as a barrier to the entry of harmful environmental allergic, toxic or <b>infectious</b> <b>substances.</b> Inherited defects in the genes encoding the components of the epidermal barrier result in the development of rare genetic disorders, whereas polymorphisms in these genes together with environmental factors cause frequent inflammatory skin diseases, such as atopic dermatitis. In this review, components of the skin-barrier function will be reviewed with special emphasis on how the altered epidermal barrier might be repaired. The different strategies to increase the transdermal penetration of drugs is also discussed...|$|E
5000|$|The {{history of}} {{virology}} - the {{scientific study of}} viruses and the infections they cause - began in the closing years of the 19th century. Although Louis Pasteur and Edward Jenner developed the first vaccines to protect against viral infections, they did not know that viruses existed. The first evidence of the existence of viruses came from experiments with filters that had pores small enough to retain bacteria. In 1892, Dmitry Ivanovsky used one of these filters to show that sap from a diseased tobacco plant remained infectious to healthy tobacco plants despite having been filtered. Martinus Beijerinck called the filtered, <b>infectious</b> <b>substance</b> a [...] "virus" [...] and this discovery is considered to be the beginning of virology. The subsequent discovery and partial characterization of bacteriophages by Felix d'Herelle further catalyzed the field, and by the early 20th century many viruses were discovered.|$|R
50|$|The pocket mask {{is a small}} {{device that}} can be carried on one's person. Air is {{administered}} to the patient when the emergency responder exhales through a one-way filter valve. Modern pocket masks have either a built in one-way valve or an attachable, disposable filter to protect the emergency responder from the patient's potentially <b>infectious</b> bodily <b>substances,</b> such as vomit or blood.|$|R
40|$|Herpes simplex virus {{infection}} is mostly spread and occurs more commonly among substance abusing adolescents {{as compared to}} the nonsubstance abusing. In this paper, a mathematical model for the spread of HSV- 2 within a community with substance abusing adolescents is developed and analysed. The impacts of condom use and educational campaigns are examined. The study suggests that condom use is highly effective among adolescents, when we have more of them quitting than becoming substance abusers. Measures such as educational campaigns can be put in place to try and reduce adolescents from becoming substance abusers. Further, we applied optimal control theory to the proposed model. The controls represent condom use and educational campaigns. The objective is based on maximising the susceptible nonsubstance abusing adolescents, while minimising the susceptible substance abusing adolescents, the infectious nonsubstance abusing adolescents, and the <b>infectious</b> <b>substance</b> abusing adolescents. We used Pontrygin’s maximum principle to characterise the optimal levels of the two controls. The resulting optimality system is solved numerically. Overall, the application of the optimal control theory suggests that more effort should be devoted to condom use as compared to educational campaigns...|$|R
40|$|Form {{of medical}} waste {{produced}} by {{health care and}} medical diagnosis and analysis laboratories, and others, a danger if not handled properly, due to <b>infectious</b> <b>substances</b> such as bacteria and viruses and the rapid proliferation of objects contaminated with patient fluids and chemicals [...] , {{the effect of these}} wastes is a significant burden for institutions increased costs of health management and treatment, and society is to increase the social costs of pollution and the environment by direct discharge to the environment (air, water, soil) and the degradation of the ocean and the spread of disease. And to protect the environment and public health risks of medical waste in health facilities {{should be aware of the}} different costs that accrue to May, and in particular the costs of disposal and reduce the source, if possible, Through this research, we try to determine the impact of medical waste, the costs of health facilitie...|$|E
40|$|Avian {{influenza}} (bird flu) is {{a disease}} of birds caused by influenza viruses closely related to human influenza viruses. The potential for transformation of avian influenza into a form that both causes severe disease in humans and spreads easily {{from person to person}} is a great concern for world health. The main purpose of a mask is to help prevent particles (droplets) being expelled into the environment by the wearer. Masks are also resistant to fluids, and help protect the wearer from splashes of blood or other potentially <b>infectious</b> <b>substances.</b> They are not necessarily designed for filtration efficiency, or to seal tightly to the face. Masks and respirators are components of a number of infection control measures intended to protect healthcare workers, and prevent the spread of diseases. All healthcare workers who come into contact with a possible or probable case of any respiratory track infections should wear a respirator conforming to at least EN 149 : 2001 FFP 3. [TAF Prev Med Bull 2006; 5 (4. 000) : 296 - 306...|$|E
40|$|This study {{reports a}} simple {{strategy}} {{to detect a}} deoxyribonucleic acid (DNA) on a membrane-based lateral flow (MBLF) strip without tedious gel preparation, gel electrophoresis, and EtBr-staining processes. The method also enhances the detection signal of the genetic sample. A direct electric field was applied over two ends of the MBLF strips to induce an electrophoresis of DNAs through the strips. The signal enhancement was demonstrated by the detection of the H 5 subtype of avian influenza virus (H 5 AIV). This approach showed an excellent selectivity of H 5 AIV from other two control species, Arabidopsis thaliana and human PSMA 5. It also showed an effective signal repeatability and sensitivity over a series of analyte concentrations. Its detection limit could be enhanced, from 40 ng to 0. 1 ng by applying 12 V. The nano-gold particles for the color development were labeled on the capture antibody, and UV-VIS and TEM were used to check if the labeling was successful. This detection strategy could be further developed to apply on the detection of drug-allergic genes at clinics or detection of <b>infectious</b> <b>substances</b> at incident sites by a simple manipulation with an aid of a mini-PCR machine and auxiliary kits...|$|E
40|$|On August 1, 2014, CDC {{released}} guidance titled, 22 ̆ 0 ac?Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U. S. Hospitals. 22 ̆ 0 ac?Ebola viruses {{are transmitted}} through {{direct contact with}} blood or body fluids/substances (e. g., urine, feces, vomit) of an infected person with symptoms or through exposure to objects (such as needles) that have been contaminated with infected blood or body fluids. The role of the environment in transmission has not been established. Limited laboratory studies under favorable conditions indicate that Ebolavirus can remain viable on solid surfaces, with concentrations falling slowly over several days. 1, 2 In the only study to assess contamination of the patient care environment during an outbreak, virus was not detected in any of 33 samples collected from sites that were not visibly bloody. However, virus was detected on a blood-stained glove and bloody intravenous insertion site. 3 There is no epidemiologic evidence of Ebolavirus transmission via either the environment or fomites that could become contaminated during patient care (e. g., bed rails, door knobs, laundry). However, given the apparent low infectious dose, potential of high virus titers {{in the blood of}} ill patients, and disease severity, higher levels of precaution are warranted to reduce the potential risk posed by contaminated surfaces in the patient care environment. As part of the care of patients who are persons under investigation, or with probable or confirmed Ebola virus infections, hospitals are recommended to: 22 ̆ 0 ac 2 Be sure environmental services staff wear recommended personal protective equipment (PPE) to protect against direct skin and mucous membrane exposure of cleaning chemicals, contamination, and splashes or spatters during environmental cleaning and disinfection activities. If reusable heavy-duty gloves are used for cleaning and disinfecting, they should be disinfected and kept in the room or anteroom. Be sure staff are instructed in the proper use of personal protective equipment including safe removal to prevent contaminating themselves or others in the process, and that contaminated equipment is disposed of appropriately. (see question 8). 22 ̆ 0 ac 2 Use a U. S. Environmental Protection Agency (EPA) -registered hospital disinfectant with a label claim for a non-enveloped virus (e. g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection. Although there are no products with specific label claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, non-enveloped viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an enveloped virus is being recommended at this time. EPA-registered hospital disinfectants with label claims against non-enveloped viruses (e. g., norovirus, rotavirus, adenovirus, poliovirus) are broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses. 22 ̆ 0 ac 2 Avoid contamination of reusable porous surfaces that cannot be made single use. Use only a mattress and pillow with plastic or other covering that fluids cannot get through. Do not place patients with suspected or confirmed Ebola virus infection in carpeted rooms and remove all upholstered furniture and decorative curtains from patient rooms before use. 22 ̆ 0 ac 2 To reduce exposure among staff to potentially contaminated textiles (cloth products) while laundering, discard all linens, non-fluid-impermeable pillows or mattresses, and textile privacy curtains into the waste stream and disposed of appropriately. The Ebola virus is a classified as a Category A <b>infectious</b> <b>substance</b> by and regulated by the U. S. Department of Transportation 22 ̆ 0 ac 2 ̆ 122 s (DOT) Hazardous Materials Regulations (HMR, 49 C. F. R., Parts 171 - 180). Any item transported offsite for disposal that is contaminated or suspected of being contaminated with a Category A <b>infectious</b> <b>substance</b> must be packaged and transported in accordance with the HMR. This includes medical equipment, sharps, linens, and used health care products (such as soiled absorbent pads or dressings, kidney-shaped emesis pans, portable toilets, used Personal Protection Equipment (gowns, masks, gloves, goggles, face shields, respirators, booties, etc.) or byproducts of cleaning) contaminated or suspected of being contaminated with a Category A <b>infectious</b> <b>substance...</b>|$|R
40|$|Supersedes the Ebola Virus Disease {{portions}} of Guidelines for environmental infection control in health-case facilities : recommendations of CDC and Healthcare Infection Control Practices Advisory Committee (HICPAC). On August 1, 2014, CDC released guidance titled, 2 ̆ 01 dInfection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U. S. Hospitals. 2 ̆ 01 dEbola viruses are transmitted through {{direct contact with}} blood or body fluids/substances (e. g., urine, feces, vomit) of an infected person with symptoms or through exposure to objects (such as needles) that have been contaminated with infected blood or body fluids. The role of the environment in transmission has not been established. Limited laboratory studies under favorable conditions indicate that Ebolavirus can remain viable on solid surfaces, with concentrations falling slowly over several days. 1, 2 In the only study to assess contamination of the patient care environment during an outbreak, virus was not detected in any of 33 samples collected from sites that were not visibly bloody. However, virus was detected on a blood-stained glove and bloody intravenous insertion site. 3 There is no epidemiologic evidence of Ebolavirus transmission via either the environment or fomites that could become contaminated during patient care (e. g., bed rails, door knobs, laundry). However, given the apparent low infectious dose, potential of high virus titers {{in the blood of}} ill patients, and disease severity, higher levels of precaution are warranted to reduce the potential risk posed by contaminated surfaces in the patient care environment. As part of the care of patients who are persons under investigation, or with probable or confirmed Ebola virus infections, hospitals are recommended to: 2 ̆ 022 Be sure environmental services staff wear recommended personal protective equipment (PPE) to protect against direct skin and mucous membrane exposure of cleaning chemicals, contamination, and splashes or spatters during environmental cleaning and disinfection activities. If reusable heavy-duty gloves are used for cleaning and disinfecting, they should be disinfected and kept in the room or anteroom. Be sure staff are instructed in the proper use of personal protective equipment including safe removal to prevent contaminating themselves or others in the process, and that contaminated equipment is disposed of appropriately. (see question 8). 2 ̆ 022 Use a U. S. Environmental Protection Agency (EPA) -registered hospital disinfectant with a label claim for a non-enveloped virus (e. g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection. Although there are no products with specific label claims against the Ebola virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, non-enveloped viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an enveloped virus is being recommended at this time. EPA-registered hospital disinfectants with label claims against non-enveloped viruses (e. g., norovirus, rotavirus, adenovirus, poliovirus) are broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses. 2 ̆ 022 Avoid contamination of reusable porous surfaces that cannot be made single use. Use only a mattress and pillow with plastic or other covering that fluids cannot get through. Do not place patients with suspected or confirmed Ebola virus infection in carpeted rooms and remove all upholstered furniture and decorative curtains from patient rooms before use. 2 ̆ 022 To reduce exposure among staff to potentially contaminated textiles (cloth products) while laundering, discard all linens, non-fluid-impermeable pillows or mattresses, and textile privacy curtains into the waste stream and disposed of appropriately. The Ebola virus is a classified as a Category A <b>infectious</b> <b>substance</b> by and regulated by the U. S. Department of Transportation 2 ̆ 019 s (DOT) Hazardous Materials Regulations (HMR, 49 C. F. R., Parts 171 - 180). Any item transported offsite for disposal that is contaminated or suspected of being contaminated with a Category A <b>infectious</b> <b>substance</b> must be packaged and transported in accordance with the HMR. This includes medical equipment, sharps, linens, and used health care products (such as soiled absorbent pads or dressings, kidney-shaped emesis pans, portable toilets, used Personal Protection Equipment (gowns, masks, gloves, goggles, face shields, respirators, booties, etc.) or byproducts of cleaning) contaminated or suspected of being contaminated with a Category A <b>infectious</b> <b>substance.</b> CurrentPrevention and ControlInfectious Diseas...|$|R
50|$|The stated {{aim of the}} Federal Office of Public Health is {{to promote}} and {{maintain}} the health of all people living in Switzerland. It seeks to increase awareness of health-related matters {{so that people can}} take responsibility for their own health. It also aims at a general improvement in people’s health through disease prevention and health protection campaigns and by curing illnesses and alleviating suffering caused by disease and accidents. The FOPH is charged with tackling issues such as epidemiology and <b>infectious</b> diseases, <b>substance</b> abuse and drug prevention, food safety, noise and radiation protection, assessment and monitoring of chemicals and toxic products, stem cell research and bioterrorism, and health and accident insurance. The FOPH is led by Director Pascal Strupler. It has a staff of 581 and has an annual budget of CHF 207 million.|$|R
40|$|Facial {{attractiveness}} is {{an important}} part of our initial judgments of people and in our ability to determine their compatibility as a mating partner. Just as mating is evolutionarily important, the emotion disgust is one of the most evolutionarily beneficial emotions as it helps keep us away from poisonous and possibly <b>infectious</b> <b>substances</b> or foods. We instinctively avoid people with facial scars and other facial deformities because these are seen as a sign of illness or generally poor well-being. Facial attraction is one component of how we choose a mate. The current experiment examined whether or not being disgusted created an avoidance behavior, in the form of lower attractiveness scores, of individuals who are not scarred similar to our desire to avoid people with scars. Disgust was induced by showing participants a series of disgusting photos prior to making attractiveness ratings of potential mating targets. It was found that individuals who were disgusted did not rate photos significantly different than participants who received a neutral mood induction or a hygienic mood induction. Possible explanations for this finding such as the hygienic induction making participants more aware of pathogens instead of feeling clean are discussed. Future research opportunities into areas like facial surgery are also discussed...|$|E
40|$|Section I. Introduction [...] Section II. Biological risk {{assessment}} [...] Section III. Principles of biosafety [...] Section IV. Laboratory biosafety level criteria [...] Section V. Vertebrate animal biosafety level criteria, for vivarium research facilities. [...] Section VI. Principles of laboratory biosecurity [...] Section VII. Occupational health and immunoprophylaxis [...] Section VIII. Agent summary statements [...] Section VIII-A. Bacterial agents [...] Section VIII-B. Fungal agents [...] Section VIII-C. Parasitic agents [...] Section VIII-D. Rickettsial agents [...] Section VIII-E. Viral agents [...] Section VIII-F. Arboviruses and related zoonotic viruses [...] Section VIII-G. Toxin agents [...] Section VIII-H. Prion diseases [...] Appendix A. Primary containment for biohazards: selection, installation {{and use of}} biological safety cabinets [...] Appendix B. Decontamination and disinfection [...] Appendix C. Transportation of <b>infectious</b> <b>substances</b> [...] Appendix D. Agriculture pathogen biosafety [...] Appendix E. Arthropod containment guidelines (ACG) [...] Appendix F. Select agents and toxins [...] Appendix G. Integrated pest management (IPM) [...] Appendix H. Working with Human, NHP and other mammalian cells and tissues [...] Appendix I. Guidelines for Work with Toxins of Biological Origin [...] Appendix J. NIH oversight of research involving recombinant biosafety issues [...] Appendix K. Resources [...] Appendix L. Acronyms[editors, L. Casey Chosewood, Deborah E. Wilson]. Shipping list no. : 2010 - 0155 -P. Includes bibliographical references and index...|$|E
40|$|I. Introduction [...] II. Requirements of a {{reference}} laboratory [...] [...] Bacterial agents of pneumonia and meningitis [...] III. Haemophilus influenzae [...] IV. Neisseria meningitidis [...] V. Streptococcus pneumoniae [...] [...] Sexually transmitted pathogen {{for which there}} are increasing antimicrobial resistance concerns [...] VI. Neisseria gonorrhoeae [...] [...] Bacterial agents of enteric diseases of public health concern [...] VIII. Salmonellaserotype Typhi [...] VIII. Shigella [...] IX. Vibrio cholerae [...] X. Conclusion [...] XI. Appendices [...] 1. Standard safety practices in the microbiology laboratory [...] 2. Media, reagents, and quality control [...] 3. Collection and transport of sterile site specimens [...] 4. Isolation and presumptive identification of agents from normally sterile sites [...] 5. Nasopharyngeal swab specimen collection and culture methodology [...] 6. Serotyping and quellung typing of Streptococcus pneumoniae [...] 7. Antimicrobial susceptibility testing by broth microdilution [...] 8. Specimen collection and primary isolation of Neisseria gonorrhoeae [...] 9. Fecal specimens:collection, transport, and field supplies [...] 10. Laboratory processing of fecal specimens [...] 11. Preservation and storage of isolates [...] 12. Packing and shipping of diagnostic specimens and <b>infectious</b> <b>substances</b> [...] 13. Manufacturer, supplier, and distributor contact information [...] 14. International reference laboratories [...] 15. Selected referencesprincipal authors, Mindy J. Perilla [...] . [et. al. ]; prepared by Centers for Disease Control, National Center for Infectious Diseases and World Health Organization, Department of Communicable Disease Surveillance and Response. "WHO/CDS/CSR/RMD/ 2003. 6 " [...] Cover. Includes bibliographical references (p. 337 - 345) and index...|$|E
40|$|Skin {{lies at the}} {{interface}} between the complex physiology {{of the body and}} the external environment. This essential epidermal barrier, composed of cornified proteins encased in lipids, prevents both water loss and entry of <b>infectious</b> or toxic <b>substances.</b> We uncover that the transcription factor GATA- 3 is required to establish the epidermal barrier and survive in the ex utero environment. Analysis of Gata- 3 mutant transcriptional profi les at three critical developmental stages identifi es a specifi c defect in lipid biosynthesis and a delay in differentiation...|$|R
40|$|Hazardous {{materials}} are matter, substances, mixtures and solutions having harmful characteristics (e. g. toxic, flammable, mutagenic). Normally a distinction is made mainly between {{the four major}} categories of chemical, <b>infectious</b> and radioactive <b>substances,</b> and explosives, with regard to possible protective measures. Technological progress has brought with it an increasing risk to mankind and nature through accidents resulting from the industrial use, manufacture or transport of such hazardous materials. At {{the same time there}} is a threat of warlike or terrorist acts. Therefore, technologies for the detection and removal of hazardous {{materials are}} of great interest...|$|R
5000|$|... "Plant pest" [...] {{is defined}} by CFR Title 7 §340.1 as [...] "Any living stage (including active and dormant forms) of insects, mites, nematodes, slugs, snails, protozoa, or other {{invertebrate}} animals, bacteria, fungi, other parasitic plants or reproductive parts thereof; viruses; or any organisms similar to or allied {{with any of the}} foregoing; or any <b>infectious</b> agents or <b>substances,</b> which can directly or indirectly injure or cause disease or damage in or to any plants or parts thereof, or any processed, manufactured, or other products of plants." [...] Thus, if genetic engineering techniques do not include introduction of such material and only include manipulation of the genomic material of the plant itself the modified organization may petition for determination of nonregulated status.|$|R
40|$|Objectives Concern {{about the}} impact of the {{environment}} on health and well-being has tended to focus on the physical effects of exposure to toxic and <b>infectious</b> <b>substances,</b> and on the impact of large-scale infrastructures. Less attention has been paid to the possible psychosocial consequences of people's subjective perceptions of their everyday, street-level environment, such as the incidence of litter and graffiti. As little is known about the potential relative importance for health of perceptions of different types of environmental incivility, a module was developed for inclusion in the 2004 Scottish Social Attitudes survey in order to investigate this relationship. Study design A random sample of 1637 adults living across a range of neighbourhoods throughout Scotland was interviewed. Methods Respondents were asked to rate their local area on a range of possible environmental incivilities. These incivilities were subsequently grouped into three domains: (i) street-level incivilities (e. g. litter, graffiti); (ii) large-scale infrastructural incivilities (e. g. telephone masts); and (iii) the absence of environmental goods (e. g. safe play areas for children). For each of the three domains, the authors examined the degree to which they were thought to pose a problem locally, and how far these perceptions varied between those living in deprived areas and those living in less-deprived areas. Subsequently, the relationships between these perceptions and self-assessed health and health behaviours were explored, after controlling for gender, age and social class. Results Respondents with the highest levels of perceived street-level incivilities were almost twice as likely as those who perceived the lowest levels of street-level incivilities to report frequent feelings of anxiety and depression. Perceived absence of environmental goods was associated with increased anxiety (2. 5 times more likely) and depression (90...|$|E
40|$|Objectives: Concern {{about the}} impact of the {{environment}} on health and well being has tended to focuson the physical effects of exposure to toxic and <b>infectious</b> <b>substances,</b> and on the impact of large scale infrastructures. Less attention has been paid to the possible psychosocial consequences of people's subjective perceptions of their everyday, street level environment, such as the incidence of litter and graffiti. As little is known about the potential relative importance for health of perceptions of different types of environmental incivility, a module was developed for inclusion in the 2004 Scottish Social Attitudes survey in order to investigate this relationship. Study design: A random sample of 1637 adults living across a range of neighbourhoods throughout Scotland was interviewed. Methods: Respondents were asked to rate their local area on a range of possible environmental incivilities. These incivilities were subsequently grouped into three domains: (i) street level incivilities (e. g. litter, graffiti); (ii) large scale infrastructural incivilities (e. g. telephone masts); and (iii) the absence of environmental goods (e. g. safe play areas for children). For each of the three domains, the authors examined the degree to which they were thought to pose a problem locally, and how far these perceptions varied between those living in deprived areas and those living in less deprived areas. Subsequently, the relationships between these perceptions and self assessed health and health behaviours were explored, after controlling for gender, age and social class. Results: Respondents with the highest levels of perceived street level incivilities were almost twice aslikely as those who perceived the lowest levels of street level incivilities to report frequent feelings of anxiety and depression. Perceived absence of environmental goods was associated with increased anxiety (2. 5 times more likely) and depression (90 % more likely), and a 50 % increased likelihood of being a smoker. Few associations with health were observed for perceptions of large scale infrastructural incivilities. Conclusions: Environmental policy needs to give more priority to reducing the incidence of street levelincivilities and the absence of environmental goods, both of which appear to be more important for health than perceptions of large scale infrastructural incivilities...|$|E
40|$|Prevention of {{injuries}} and occupational infections in U. S. laboratories {{has been a}} concern for many years. CDC and the National Institutes of Health addressed the topic in their publication Biosafety in Microbiological and Biomedical Laboratories, now in its 5 th edition (BMBL- 5). BMBL- 5, however, was not designed to address the day-to-day operations of diagnostic laboratories in human and animal medicine. In 2008, CDC convened a Blue Ribbon Panel of laboratory representatives {{from a variety of}} agencies, laboratory organizations, and facilities to review laboratory biosafety in diagnostic laboratories. The members of this panel recommended that biosafety guidelines be developed to address the unique operational needs of the diagnostic laboratory community and that they be science based and made available broadly. These guidelines promote a culture of safety and include recommendations that supplement BMBL- 5 by addressing the unique needs of the diagnostic laboratory. They are not requirements but recommendations that represent current science and sound judgment that can foster a safe working environment for all laboratorians. Throughout these guidelines, quality laboratory science is reinforced by a common-sense approach to biosafety in day-to-day activities. Because many of the same diagnostic techniques are used in human and animal diagnostic laboratories, the text is presented with this in mind. All functions of the human and animal diagnostic laboratory [...] microbiology, chemistry, hematology, and pathology with autopsy and necropsy guidance [...] are addressed. A specific section for veterinary diagnostic laboratories addresses the veterinary issues not shared by other human laboratory departments. Recommendations for all laboratories include use of Class IIA 2 biological safety cabinets that are inspected annually; frequent hand washing; use of appropriate disinfectants, including 1 : 10 dilutions of household bleach; dependence on risk assessments for many activities; development of written safety protocols that address the risks of chemicals in the laboratory; the need for negative airflow into the laboratory; areas of the laboratory in which use of gloves is optional or is recommended; and the national need for a central site for surveillance and nonpunitive reporting of laboratory incidents/exposures, injuries, and infections [...] " -p. 11. Introduction: a culture of safety for diagnostic laboratories [...] 2. Biological risk assessment and biosafety guidelines [...] 3. Fundamental safety practices in diagnostic laboratories [...] 4. Tuberculosis laboratory [...] 5. Autopsy/necropsy, surgical pathology [...] 6. Parasitology laboratory [...] 7. Mycology laboratory [...] 8. Virology laboratory [...] 9. Chemistry laboratory [...] 10. Hematology and phlebotomy laboratory [...] 11. Blood bank [...] 12. Veterinary diagnostic laboratory [...] 13. Storing, packaging, and shipping <b>infectious</b> <b>substances</b> [...] 14. Emergency procedures and responsibilities [...] 15. Biosafety education [...] 16. Continuous quality improvement [...] References [...] Appendix: Job safety analysis sample formprepared by J. Michael Miller, Rex Astles, Timothy Baszler, Kimberle Chapin, Roberta Carey, Lynne Garcia, Larry Gray, Davise Larone, Michael Pentella, Anne Pollock, Daniel S. Shapiro, Elizabeth Weirich, Danny Wiedbrauk. "January 6, 2012. ""The material in this report originated in the National Center for Emerging and Zoonotic Infectious Diseases. " - p. 1 Also available via the World Wide Web as an Acrobat. pdf file (1. 37 MB, 105 p.). Includes bibliographical references (p. 95 - 100) ...|$|E
40|$|Skin {{is at the}} {{interface}} between the complex physiology {{of the body and}} the external, often hostile, environment, and the semipermeable epidermal barrier prevents both the escape of moisture and the entry of <b>infectious</b> or toxic <b>substances.</b> Newborns with rare congenital barrier defects underscore the skin’s essential role in a terrestrial environment and demonstrate the compensatory responses evoked ex utero to reestablish a barrier. Common inflammatory skin disorders such as atopic dermatitis and psoriasis exhibit decreased barrier function, and recent studies suggest that the complex response of epidermal cells to barrier disruption may aggravate, maintain, or even initiate such conditions. Either aiding barrier reestablishment or dampening the epidermal stress response may improve the treatment of these disorders. This Review discusses the molecular regulation of the epidermal barrier as well as causes and potential treatments for defects of barrier formation and proposes that medical management of barrier disruption may positively affect the course of common skin disorders...|$|R
40|$|Skin {{lies at the}} {{interface}} between the complex physiology {{of the body and}} the external environment. This essential epidermal barrier, composed of cornified proteins encased in lipids, prevents both water loss and entry of <b>infectious</b> or toxic <b>substances.</b> We uncover that the transcription factor GATA- 3 is required to establish the epidermal barrier and survive in the ex utero environment. Analysis of Gata- 3 mutant transcriptional profiles at three critical developmental stages identifies a specific defect in lipid biosynthesis and a delay in differentiation. Genomic analysis identifies highly conserved GATA- 3 binding sites bound in vivo by GATA- 3 in the first intron of the lipid acyltransferase gene AGPAT 5. Skin from both Gata- 3 −/− and previously characterized barrier-deficient Kruppel-like factor 4 −/− newborns up-regulate antimicrobial peptides, effectors of innate immunity. Comparison of these animal models illustrates how impairment of the skin barrier by two genetically distinct mechanisms leads to innate immune responses, as observed in the common human skin disorders psoriasis and atopic dermatitis...|$|R
40|$|This report {{summarizes}} current (as of 2011) guidelines or recommendations {{published by}} multiple {{agencies of the}} U. S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services. Implementing integrated services for prevention of HIV infection, viral hepatitis, STDs, and TB is intended to provide persons who use drugs illicitly with increased access to services, to improve timeliness of service delivery, and to increase effectiveness of efforts to prevent infectious diseases that share common risk factors, behaviors, and social determinants. This guidance is intended for use by decision makers (e. g., local and federal agencies and leaders and managers of prevention and treatment services), health-care providers, social service providers, and prevention and treatment support groups. Consolidated guidance can strengthen efforts of health-care providers and public health providers to prevent and treat <b>infectious</b> diseases and <b>substance</b> use and mental disorders, use resources efficiently, and improve health-care services and outcomes in persons who use drugs illicitly. An integrated approach to service delivery for persons who use drugs incorporates recommended science-based public health strategies, including 1) prevention and treatment of substance use and mental disorders; 2) outreach programs; 3) risk assessment for illicit use of drugs; 4) risk assessment for infectious diseases; 5) screening, diagnosis, and counseling for infectious diseases; 6) vaccination; 7) prevention of mother-to-child transmission of infectious diseases; 8) interventions for reduction of risk behaviors; 9) partner services and contact follow-up; 10) referrals and linkage to care; 11) medical treatment for infectious diseases; and 12) delivery of integrated prevention services. These strategies are science-based, public health strategies to prevent and treat <b>infectious</b> diseases, <b>substance</b> use disorders, and mental disorders. Treatment of infectious diseases and treatment of substance use and mental disorders contribute to prevention of transmission of infectious diseases. Integrating prevention services can increase access to and timeliness of prevention and treatment. Introduction [...] Guidance development methods [...] Epidemiology of illicit use of drugs and of HIV infection, viral hepatitis, STDs, TB, and their sequelae in the United States [...] Science-based public health strategies for prevention [...] Special considerations for prevention and control of infectious diseases [...] Practical aspects of delivery of integrated prevention services [...] Conclusion [...] Acknowledgments [...] References [...] Appendix A: Search and evidence acquisition for the guidance [...] Appendix B: Recommendations and guidelinesprepared by Hrishikesh Belani [...] . [et al. ]. "November 9, 2012. "This report originated in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Also available via the World Wide Web. Includes bibliographical references (p. 42 - 43) ...|$|R
